Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein
- Authors:
- Fumio Yamaguchi
- Sumio Hayakawa
- Shota Kawashima
- Takayuki Asakura
- Yumiko Oishi
-
Affiliations: Department of Neurosurgery for Community Health, Nippon Medical School, Tokyo 1138603, Japan, Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo 1138603, Japan, Faculty of Medicine, Nippon Medical School, Tokyo 1138603, Japan - Published online on: May 11, 2022 https://doi.org/10.3892/ijo.2022.5370
- Article Number: 80
This article is mentioned in:
Abstract
Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD and Paggi MG: Drug repurposing for the treatment of glioblastoma multiforme. J Exp Clin Cancer Res. 36:1692017. View Article : Google Scholar : PubMed/NCBI | |
Albayrak G, Konac E, Dikmen AU and Bilen CY: Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells. Hum Exp Toxicol. 37:953–958. 2018. View Article : Google Scholar | |
Albayrak G and Korkmaz FD: Alzheimer's drug memantine inhibits metastasis and p-Erk protein expression on 4T1 breast cancer cells. Bratisl Lek Listy. 121:499–503. 2020.PubMed/NCBI | |
Lipton SA: Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov. 5:160–170. 2006. View Article : Google Scholar : PubMed/NCBI | |
Müller-Längle A, Lutz H, Hehlgans S, Rödel F, Rau K and Laube B: NMDA receptor-mediated signaling pathways enhance radiation resistance, survival and migration in glioblastoma cells-a potential target for adjuvant radiotherapy. Cancers (Basel). 11:5032019. View Article : Google Scholar | |
Yoshioka A, Ikegaki N, Williams M and Pleasure D: Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell lines. J Neurosci Res. 46:164–178. 1996. View Article : Google Scholar : PubMed/NCBI | |
Choi SW, Park SY, Hong SP, Pai H, Choi JY and Kim SG: The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma. J Oral Pathol Med. 33:533–537. 2004. View Article : Google Scholar : PubMed/NCBI | |
Stepulak A, Luksch H, Uckermann O, Sifringer M, Rzeski W, Polberg K, Kupisz K, Klatka J, Kielbus M, Grabarska A, et al: Glutamate receptors in laryngeal cancer cells. Anticancer Res. 31:565–573. 2011.PubMed/NCBI | |
Liu JW, Myoung SK, Nagpal J, Yamashita K, Poeta L, Chang X, Lee J, Park HL, Jeronimo C, Westra WH, et al: Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer. 121:1994–2000. 2007. View Article : Google Scholar : PubMed/NCBI | |
Watanabe K, Kanno T, Oshima T, Miwa H, Tashiro C and Nishizaki T: The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells. Biochem Biophys Res Commun. 367:487–490. 2008. View Article : Google Scholar : PubMed/NCBI | |
Abdul M and Hoosein N: N-methyl-D-aspartate receptor in human prostate cancer. J Membr Biol. 205:125–128. 2005. View Article : Google Scholar | |
Sekiguchi K, Sato M, Yokoyama MK, Sato T, Tsutiya A, Omoteyama K, Arito M, Suematsu N, Kato T and Kurokawa M: Effects of memantine on the growth and protein profiles of neuroblastoma cells. Integr Mol Med. 5:1–8. 2018. View Article : Google Scholar | |
North WG, Liu F, Dragnev KH and Demidenko E: Small-cell lung cancer growth inhibition: Synergism between NMDA receptor blockade and chemotherapy. Clin Pharmacol. 11:15–23. 2019. | |
Du S, Sung YS, Wey M, Wang Y, Alatrash N, Berthod A, MacDonnell FM and Armstrong DW: Roles of N-methyl-D-aspartate receptors and D-amino acids in cancer cell viability. Mol Biol Rep. 47:6749–6758. 2020. View Article : Google Scholar : PubMed/NCBI | |
Kamal T, Green TN, Morel-Kopp MC, Ward CM, McGregor AL, McGlashan SR, Bohlander SK, Browett PJ, Teague L, During MJ, et al: Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation. Cell Signal. 27:1860–1872. 2015. View Article : Google Scholar | |
Rzeski W, Turski L and Ikonomidou C: Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA. 98:6372–6377. 2001. View Article : Google Scholar : PubMed/NCBI | |
Turner N and Grose R: Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer. 10:116–129. 2010. View Article : Google Scholar : PubMed/NCBI | |
Katoh M: Therapeutics targeting FGF signaling network in human diseases. Trends Pharmacol Sci. 37:1081–1096. 2016. View Article : Google Scholar | |
Tiong KH, Mah LY and Leong CO: Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Apoptosis. 18:1447–1468. 2013. View Article : Google Scholar : PubMed/NCBI | |
Presta M, Chiodelli P, Giacomini A, Rusnati M and Ronca R: Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach. Pharmacol Ther. 179:171–187. 2017. View Article : Google Scholar : PubMed/NCBI | |
De Luca A, Esposito Abate R, Rachiglio AM, Maiello MR, Esposito C, Schettino C, Izzo F, Nasti G and Normanno N: FGFR fusions in cancer: From diagnostic approaches to therapeutic intervention. Int J Mol Sci. 21:68562020. View Article : Google Scholar | |
Tomlinson DC and Knowles MA: Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am J Pathol. 177:2379–2386. 2010. View Article : Google Scholar | |
Zhu DL, Tuo XM, Rong Y, Zhang K and Guo Y: Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers. J Cancer. 11:7264–7275. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hierro C, Rodon J and Tabernero J: Fibroblast growth factor (FGF) receptor/FGF inhibitors: Novel targets and strategies for optimization of response of solid tumors. Semin Oncol. 42:801–819. 2015. View Article : Google Scholar | |
Gross JL, Morrison RS, Eidsvoog K, Herblin WF, Kornblith PL and Dexter DL: Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growth. J Neurosci Res. 27:689–696. 1990. View Article : Google Scholar : PubMed/NCBI | |
Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H and Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: Demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA. 87:5710–5714. 1990. View Article : Google Scholar : PubMed/NCBI | |
Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanda AM, Donehower LA and Berger M: Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol. 18:207–216. 1994. View Article : Google Scholar | |
Hynes NE and Dey JH: Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res. 70:5199–5202. 2010. View Article : Google Scholar : PubMed/NCBI | |
Santolla MF and Maggiolini M: The FGF/FGFR system in breast cancer: Oncogenic features and therapeutic perspectives. Cancers (Basel). 12:30292020. View Article : Google Scholar | |
Burrus LW, Zuber ME, Lueddecke BA and Olwin BB: Identification of a cysteine-rich receptor for fibroblast growth factors. Mol Cell Biol. 12:5600–5609. 1992. View Article : Google Scholar | |
Steegmaier M, Levinovitz A, Isenmann S, Borges E, Lenter M, Kocher HP, Kleuser B and Vestweber D: The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 373:615–620. 1995. View Article : Google Scholar : PubMed/NCBI | |
Croul S, Mezitis SG, Stieber A, Chen YJ, Gonatas JO, Goud B and Gonatas NK: Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus. J Histochem Cytochem. 38:957–963. 1990. View Article : Google Scholar : PubMed/NCBI | |
Gonatas JO, Mezitis SG, Stieber A, Fleischer B and Gonatas NK: MG-160. A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus [published eeratum appears in J Biol Chem 1989 Mar 5;264(7):4264]. J Biol Chem. 264:646–653. 1989. View Article : Google Scholar : PubMed/NCBI | |
Burrus LW and Olwin BB: Isolation of a receptor for acidic and basic fibroblast growth factor from embryonic chick. J Biol Chem. 264:18647–18653. 1989. View Article : Google Scholar : PubMed/NCBI | |
Steegmaier M, Borges E, Berger J, Schwarz H and Vestweber D: The E-selectin-ligand ESL-1 is located in the Golgi as well as on microvilli on the cell surface. J Cell Sci. 110:687–694. 1997. View Article : Google Scholar | |
Levinovitz A, Mühlhoff J, Isenmann S and Vestweber D: Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol. 121:449–459. 1993. View Article : Google Scholar | |
Lenter M, Levinovitz A, Isenmann S and Vestweber D: Monospecific and common glycoprotein ligands for E- and P-selectin on myeloid cells. J Cell Biol. 125:471–481. 1994. View Article : Google Scholar | |
Mourelatos Z, Gonatas JO, Cinato E and Gonatas NK: Cloning and sequence analysis of the human MG160, a fibroblast growth factor and E-selectin binding membrane sialoglycoprotein of the Golgi apparatus. DNA Cell Biol. 15:1121–1128. 1996. View Article : Google Scholar | |
Gonatas JO, Mourelatos Z, Stieber A, Lane WS, Brosius J and Gonatas NK: MG-160, a membrane sialoglycoprotein of the medial cisternae of the rat Golgi apparatus, binds basic fibroblast growth factor and exhibits a high level of sequence identity to a chicken fibroblast growth factor receptor. J Cell Sci. 108:457–467. 1995. View Article : Google Scholar | |
Köhl R, Antoine M, Olwin BB, Dickson C and Kiefer P: Cysteine-rich fibroblast growth factor receptor alters secretion and intracellular routing of fibroblast growth factor 3. J Biol Chem. 275:15741–15748. 2000. View Article : Google Scholar | |
Ahn J, Febbraio M and Silverstein RL: A novel isoform of human Golgi complex-localized glycoprotein-1 (also known as E-selectin ligand-1, MG-160 and cysteine-rich fibroblast growth factor receptor) targets differential subcellular localization. J Cell Sci. 118:1725–1731. 2005. View Article : Google Scholar | |
Zuber ME, Zhou Z, Burrus LW and Olwin BB: Cysteine-rich FGF receptor regulates intracellular FGF-1 and FGF-2 levels. J Cell Physiol. 170:217–227. 1997. View Article : Google Scholar | |
Szebenyi G and Fallon JF: Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol. 185:45–106. 1999. View Article : Google Scholar | |
Welch WC, Morrison RS, Gross JL, Gollin SM, Kitson RB, Goldfarb RH, Giuliano KA, Bradley MK and Kornblith PL: Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cell Dev Biol Anim. 31:610–616. 1995. View Article : Google Scholar : PubMed/NCBI | |
An Q, Fillmore HL, Vouri M and Pilkington GJ: Brain tumor cell line authentication, an efficient alternative to capillary electrophoresis by using a microfluidics-based system. Neuro Oncol. 16:265–273. 2014. View Article : Google Scholar | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
Solomon E, Borrow J and Goddard AD: Chromosome aberrations and cancer. Science. 254:1153–1160. 1991. View Article : Google Scholar : PubMed/NCBI | |
Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 61:759–767. 1990. View Article : Google Scholar | |
Yamaguchi F, Saya H, Bruner JM and Morrison RS: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA. 91:484–488. 1994. View Article : Google Scholar : PubMed/NCBI | |
Jimenez-Pascual A and Siebzehnrubl FA: Fibroblast growth factor receptor functions in glioblastoma. Cells. 8:7152019. View Article : Google Scholar | |
Yamada SM, Yamaguchi F, Brown R, Berger MS and Morrison RS: Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression. Glia. 28:66–76. 1999. View Article : Google Scholar | |
Schlessinger J, Lax I and Lemmon M: Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell. 83:357–360. 1995. View Article : Google Scholar | |
Yamaguchi F, Morrison RS, Gonatas NK, Takahashi H, Sugisaki Y and Teramoto A: Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: An index of malignancy in astrocytomas. Int J Oncol. 22:1045–1049. 2003. | |
Song SW, Cote GJ, Wu C and Zhang W: Alternative splicing: Genetic complexity in cancer. Computational and Statistical Approaches to Genomics. Zhang W and Shmulevich I: Kluwer Academic Publishers; Bostan: pp. 277–297. 2002 | |
Wang Y, Liu J, Huang BO, Xu YM, Li J, Huang LF, Lin J, Zhang J, Min QH, Yang WM and Wang XZ: Mechanism of alternative splicing and its regulation. Biomed Rep. 3:152–158. 2015. View Article : Google Scholar : PubMed/NCBI | |
Hou JZ, Kan MK, McKeehan K, McBride G, Adams P and McKeehan WL: Fibroblast growth factor receptors from liver vary in three structural domains. Science. 251:665–668. 1991. View Article : Google Scholar : PubMed/NCBI | |
Werner S, Duan DS, de Vries C, Peters KG, Johnson DE and Williams LT: Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol. 12:82–88. 1992. View Article : Google Scholar | |
Crumley G, Bellot F, Kaplow JM, Schlessinger J, Jaye M and Dionne CA: High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF. Oncogene. 6:2255–2262. 1991.PubMed/NCBI | |
Dell KR and Williams LT: A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem. 267:21225–21229. 1992. View Article : Google Scholar : PubMed/NCBI | |
Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AML and Aaronson SA: Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA. 89:246–250. 1992. View Article : Google Scholar : PubMed/NCBI | |
Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y and Givol D: A confined variable region confers ligand specificity on fibroblast growth factor receptors: Implications for the origin of the immunoglobulin fold. EMBO J. 11:1885–1890. 1992. View Article : Google Scholar : PubMed/NCBI | |
Morrison RS, Yamaguchi F, Bruner JM, Tang M, McKeehan W and Berger MS: Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res. 54:2794–2799. 1994.PubMed/NCBI | |
Yamamoto-Hino M, Abe M, Shibano T, Setoguchi Y, Awano W, Ueda R, Okano H and Goto S: Cisterna-specific localization of glycosylation-related proteins to the Golgi apparatus. Cell Struct Funct. 37:55–63. 2012. View Article : Google Scholar | |
Antoine M, Köhl R, Tag CG, Gressner AM, Hellerbrand C and Kiefer P: Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases. Biochem Biophys Res Commun. 382:359–364. 2009. View Article : Google Scholar : PubMed/NCBI | |
Chen R, Xu X, Tao Y, Qian Z and Yu Y: Exosomes in hepatocellular carcinoma: A new horizon. Cell Commun Signal. 17:12019. View Article : Google Scholar | |
Yohay K, Tyler B, Weaver KD, Pardo AC, Gincel D, Blakeley J, Brem H and Rothstein JD: Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models. J Neurosurg. 120:854–863. 2014. View Article : Google Scholar : PubMed/NCBI | |
Ribeiro MPC, Nunes-Correia I, Santos AE and Custódio JBA: The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells. Exp Cell Res. 321:288–296. 2014. View Article : Google Scholar : PubMed/NCBI | |
Albayrak G and Demirtas Korkmaz F: Memantine shifts cancer cell metabolism via AMPK1/2 mediated energetic switch in A549 lung cancer cells. EXCLI J. 20:223–231. 2021.PubMed/NCBI | |
Albayrak G, Konac E, Dere UA and Emmez H: Targeting cancer cell metabolism with metformin, dichloroacetate and memantine in glioblastoma (GBM). Turk Neurosurg. 31:233–237. 2021.PubMed/NCBI | |
Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ and Forette F: Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300). Stroke. 33:1834–1839. 2002. View Article : Google Scholar : PubMed/NCBI | |
Sonkusare SK, Kaul CL and Ramarao P: Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope. Pharmacol Res. 51:1–17. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yang Z, Zhou X and Zhang Q: Effectiveness and safety of memantine treatment for Alzheimer's disease. J Alzheimers Dis. 36:445–458. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fayein NA, Head MW, Jeanny JC, Courtois Y and Fuhrmann G: Expression of the chicken cysteine-rich fibroblast growth factor receptor (CFR) during embryogenesis and retina development. J Neurosci Res. 43:602–612. 1996. View Article : Google Scholar : PubMed/NCBI |